Chembio secures FDA EUA authorization for Ebola virus diagnostic test
Nov 13, 2018 @ 14:03

Point-of-care diagnostics firm Chembio Diagnostics has secured emergency use authorization from the US Food and Drug Administration (FDA) for its Ebola virus diagnostic test. Chembio said the EUA status has been provided for the DPP Ebola antigen system for use with human capillary fingerstick whole blood, EDTA venous whole blood and EDTA plasma.

Sourced through from:

Leave a Reply